Hyperthermia and paclitaxel-epirubicin chemotherapy: enhanced cytotoxic effect in a murine mammary adenocarcinoma

References

• BAJORKO, P., FLAMIGNI, A., VOLPI, A., FEDRIGA, R., SERRA, P., MILANDRI, C., and FLAMINI, E., 1994, Carcinoma della mammella: valutazione 1in vitro della attivita‘cito-tossica della associazione farmacologica di taxolo e adriamicina. Proceeding of the XII Riunione Nazionale di Oncologia Sperimentale e Clinica. Tumori, 80, 107.
   Google Scholar
• BARRANCO, S. C., 1986, Cellular and molecular effects of adriamycin on dividing and non-dividing cells. Cell cycle effects of drugs, edited by L. A. Dethlefsen (New York: Pergamon Press), pp. 251–263.
   Google Scholar
• CHEVILLARD, S., VIELH, P., BASTIAN, G., and COPPEY, J., 1992, A single 24h contact time with adriamycin provokes the emergence of resistant cells expressing the Gp 170 pro-tein. Anticancer Research, 12, 495–500.
   PubMed Web of Science ®Google Scholar
• CIVIDALLI, A., ARCANGELI, G., CRUCIANI, G., LIVDI, E., CORDELLI, E., and TIRINDELLI DANESI, D., 1998a, Enhancement of radiation response by paclitaxel in mice according to different treatment schedules. International Journal of Radiation Oncology Biology Physics, 40, 1163–1170.
   PubMedGoogle Scholar
• CIVIDALLI, A., CRUCIANI, G., LIVDI, E., CORDELLI, E., ELETTI, B., and TIRINDELLI DANESI, D., 1998b, Greater antitumor efficacy of paclitaxel administered before epirubicin in a mouse mammary carcinoma. Journal of Cancer Research and Clinical Oncology, 124, 236–244.
   PubMed Web of Science ®Google Scholar
• CIVIDALLI, A., CRUCIANI, G., LIVDI, E., PASQUALETTI, P., and TIRINDELLI DANESI, D., 1999, Hyperthermia enhances the response of paclitaxel and radiation in mouse adenocarci-noma. International Journal of Radiation Oncology Biology Physics, 44, 407–412.
   PubMed Web of Science ®Google Scholar
• CIVIDALLI, A., TIRINDELLI DANESI, D., ALTAVISTA, P., BONANNI, M., PERSIANI, D., SEGRE, L, and CRUCIAM, G., 1995, 4'Epi-doxorubicin and hyperthermia in a murine mam-mary carcinoma: influence of the dose and fractionation. Anticancer Research, 15, 739–744.
   PubMedGoogle Scholar
• CIVIDALLI, A., TIRINDELLI DANESI, D., CRUCIAM, G., Lavin, E., CECIARELLI, F., JANIKOWSKA, S., LUNELLI, L, and PEDERZOLLI, C., 1998d, Effects of hyperthermia on free and encapsulated mitoxantr one: results from in vitro and in vivo experiments. Proceeding of International Congress Hyperthermia in Clinical Oncology, 38.
   Google Scholar
• COOX, J. A., DEGRAFF, W., and MITCHELL, J. B., 1995, Combined hyperthermia and pacli-taxel treatments in human and rodent cell lines. Proceedings of Tenth International Congress of Radiation Research, edited by U. Hagen, H. Jung and C. Streffer (Universitätsdruckerei H. Stiirts AG, Wärzburg), Vol. 1, 398.
   Google Scholar
• DECORTI, G., BARTOLI KLUGMANN, F., CANDUSSIO, L., and BALDINI, L., 1996, Effect of paclitaxel and Cremophor EL on mast cell histamine secretion and their interaction with adriamycin. Anticancer Research, 16, 317–320.
   PubMedGoogle Scholar
• ENGELHARDT, R., 1987, Hyperthermia and drugs. Recent results in cancer research, edited by C. Streffer (Berlin, Heidelberg: Springer-Verlag), pp.136–203.
   Google Scholar
• GEL, J., BOESGAARD, M., PAASKE, T., JENSEN, B.V., and DOMBERNOWSKY, P., 1996, Paclitaxel and doxorubicin in metastatic breast cancer. Seminars in Oncology, 23, 35-38. GIANNI, L., MUNZ ONE, E., CAPRI, G., VILLANI, F., SPREAFICO, C., TARENZ I, E., FULFARO, F., CARACENI, A., MARTINI, C., LAFFRANCHI, A., VALGUSSA, P., and BONADONNA, G., 1995, Paclitaxel in metastatic breast cancer: a trial of two doses by a 3-hour infusion in patients with disease recurrence after prior therapy with anthracyclines. Journal of National Cancer Institute, 87, 1169–1175.
   Google Scholar
• HAHN, S. M., LIEBMANN, J. E., COOK, J., FISHER, J., GOLDSPIEL, B., VENZON, D., MITCHELL, J. B., and KAUFMAN, D., 1993, Taxol in combination with doxorubicin or etoposide. Cancer, 72, 2705–2711.
   PubMed Web of Science ®Google Scholar
• HOLMES, F. A., MADDEN, T., NEWMAN, R. A., VALERO, V., THERIAULT, R. L, FRASCHINI, G., WALTERS, R. S., BOOSER, D. J., BUZDAR, A. U., WILLEY, J., and HORTOBAGYI, G. N, 1996, Sequence-dependent alteration of doxorubicin pharmacokinetics by pacli-taxel in a phase I study of paclitaxel and doxorubicin in patients with metastatic breast cancer. Journal of Clinical Oncology, 14, 2713–2721.
   PubMed Web of Science ®Google Scholar
• KNOX, J. D., MITCHEL, R. E. J., and BROWN, D. L., 1991, Effects of hyperthermia on micro-tubule organization and cytolytic activity of murine cytotoxic T lymphocytes. Experimental Cell Research, 194, 275–283.
   PubMed Web of Science ®Google Scholar
• KNOX, J. D., MITCHEL, R. E. J., and BROWN, D. L., 1993, Effects of taxol and taxol/hyper-thermia treatments on the functional polarization of cytotoxic T lymphocytes. Cell Motility and the Cytoskeleton, 24, 129–138.
   PubMedGoogle Scholar
• LONG, B. H., and FAIRCHILD, C. R., 1994, Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telophase. Cancer Research, 54, 4355–4361.
   PubMed Web of Science ®Google Scholar
• LUCK, H.-J., THOMSSEN, C., DU Bois, A., liSBOA, B. W., UNTCH, M., KUHNLE, H., JANICKE, F., MEERPOHL, H.-G., LINDNER, C., KONECNY, G., HECKER, D., and DIERGARTEN, K., 1997, Preliminary results of phase II study of Epirubicin and Paclitaxel as first-line treatment in patients with metastatic breast cancer. Seminars in Oncology, 24 (S3), 13–16.
   Google Scholar
• MANFREDI, J. J., and HoRwrrz, S. B., 1986, Taxol: an antimitotic agent with a new mechan-ism of action. Cell cycle effects of drugs, edited by L. A. Dethlefsen (New York: Pergamon Press), pp. 287–333.
   Google Scholar
• MARINO, C., and CIVIDALLI, A., 1992, Combined radiation and hyperthermia: effects of the number of heat fractions and their interval on normal and tumour tissues. International Journal of Hyperthermia, 8,771–781.
   PubMed Web of Science ®Google Scholar
• MAURO, F., CIVIDALLI, A., ADAMI, M., PARDINI, M. C., and ARCANGELI, G., 1983, Relative effectiveness of X-ray multifraction schedules: experiments on a murine tumor system in vivo. Proceeding of the 4th International Congress of Radiation Research (ICRR), edited by J. J. Broerse, G. W. Barendsen, H. B. Kal and A. j. Van der Kogel (Martinus Nijhoff) D1–22.
   Google Scholar
• OVERGAARD, J., 1980, Simultaneous and sequential hyperthermia and radiation treatment of an experimental tumor and its surrounding normal tissue in vivo. International Journal of Radiation Oncology Biology and Physics, 6, 1507–1517.
   PubMed Web of Science ®Google Scholar
• PULKKINEN, J. O., ELOMAA, L., JoENsuu, H., MARTIKAINEN, P., SERVOMAA, K., and GRNMAN, R., 1996, Paclitaxel-induced apoptotic changes followed by time-lapse video microscopy in cell lines established from head and neck cancer. Journal of Cancer Research and Clinical Oncology, 122, 214–218.
   PubMedGoogle Scholar
• RIETBROEK, R. C., KATSCHINSKI, D. M., REIJERS, M. H. E., ROBINS, H. I., GEERDINK, A., TUTSCH, K., D'OLEIRE, F., and HAVEMAN, J., 1997, Lack of thermal enhancement for taxanes in vitro. International Journal of Hyperthermia, 13, 525–533.
   Google Scholar
• ROWINSKY, E. K., CAZENAVE, L. A., and DONEHOWER, R. C., 1990, Taxol: a novel investigational antimicrotubule agent. Journal of the National Cancer Institute, 82, 1247-1259. WEISS, R. B., 1992, The Anthracyclines: Will We Ever Find a Better Doxorubicin? Seminars in Oncology, 19, 670–686.
   Google Scholar